Iprasure Pulmicaps 100mcg/40mcg Capsule
Images are for reference. Actual packaging may vary.
Salbutamol (100mcg) + Ipratropium (40mcg)
Bottle of 30 capsules • Capsule
A valid prescription is required for this medicine.
Haven’t found an alternative? A health advisor can help you understand what to do next.
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
+1 more active ingredient
Salbutamol activates beta-2 adrenergic receptors in the bronchial smooth muscle, leading to relaxation and bronchodilation.
Medical applications
Iprasure Pulmicaps 100mcg/40mcg Capsule is a combination bronchodilator containing Salbutamol sulfate (100mcg) and Ipratropium bromide (40mcg), indicated for the management of chronic obstructive pulmonary disease (COPD) and asthma. Salbutamol is a selective β2-adrenergic receptor agonist that provides rapid bronchodilation by relaxing bronchial smooth muscle, thereby alleviating bronchospasm and improving airflow.
Ipratropium is an anticholinergic agent that blocks muscarinic receptors in the airways, reducing bronchoconstriction and mucus secretion. The synergistic action of these two agents results in enhanced bronchodilation and symptomatic relief in obstructive airway diseases. Iprasure Pulmicaps are typically administered via inhalation, allowing targeted delivery to the lungs with minimal systemic absorption, thus reducing the risk of systemic side effects.
This combination is particularly beneficial in patients who do not achieve adequate control with monotherapy. It is essential to use this medication under medical supervision, adhering to prescribed dosages to avoid potential adverse effects such as tachycardia, dry mouth, or tremors. Iprasure Pulmicaps should be used as part of a comprehensive treatment plan including avoidance of triggers and regular monitoring of pulmonary function.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Iprasure Pulmicaps 100mcg/40mcg Capsule may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Iprasure Pulmicaps 100mcg/40mcg Capsule is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Iprasure Pulmicaps 100mcg/40mcg Capsule may not be needed in these patients. Please consult your doctor.
Exercise Caution
Iprasure Pulmicaps 100mcg/40mcg Capsule may cause side effects which could affect your ability to drive. You may feel dizzy, or have difficulty in focusing, or blurred vision while taking Iprasure Pulmicaps 100mcg/40mcg Capsule
Consult Doctor
There is limited information available on the use of Iprasure Pulmicaps 100mcg/40mcg Capsule in patients with liver disease. Please consult your doctor.
Regular Checkup
0 reviews for Iprasure Pulmicaps 100mcg/40mcg Capsule







